Skip to main content

European network for research in light ion hadron therapy (ENLIGHT)

Objective

Cancer is 2nd only to heart disease as cause of premature death. Surgery and radiotherapy (RT) are thus far the only available tools for non-systemic curative treatment. 40% of the cured patients received RT. Still, 25 to 30% of them will die due to local failure related to radio-resistance. This problem could be overcome by using a new type of beam : light ions. Regional consortia in 5 EU countries are developing with robust national funding a clinical facility to deliver this treatment. Most of them will use the PIMMS accelerator developed by the CERN research centre. RTD in the clinical assessment (indications and trials), in a common beam delivery system, biological dose optimisation, PET on line for dose verification, treatment planning and cost-efficiency studies could be shared. A concerted approach to the industrial spin-offs will cut costs and reinforce Europe's health technology sector. This is the aim of ENLIGHT.

Funding Scheme

THN - Thematic network contracts

Coordinator

EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY
Address
Av. E. Mounier, 83/4
1200 Bruxelles
Belgium

Participants (10)

CHARLES UNIVERSITY PRAGUE
Czechia
Address
2,U Nemocnice 2
128 08 Praha 2
EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH
Switzerland
Address

1211 Geneve
FONDAZIONE PER ADROTERAPIA ONCOLOGICA (TERA)
Italy
Address
Via Cozzi 53
20125 Milano
GERMAN CANCER RESEARCH CENTER
Germany
Address
Im Neuenheimer Feld 280
69120 Heidelberg
GESELLSCHAFT FUER SCHWERIONENFORSCHUNG MBH
Germany
Address
Planck Strasse 1
64291 Darmstadt
HOPITAL VIRGEN MACARENA
Spain
Address
C/ Dr Fedriani, 3
41009 Sevilla
KAROLINSKA INSTITUTE
Sweden
Address

171 76 Stockholm
RESEARCH CENTER ROSSENDORF
Germany
Address

01314 Weissig - Dresden
UNIVERSITE CLAUDE BERNARD LYON 1
France
Address
Batiment Gabriel Lippmann, Boulevard Du 11 Novembr
69622 Villeurbanne
UNIVERSITY OF VIENNA
Austria
Address
Waehringer Guertel 18-20
1090 Wien